Table 4 shows that 88.9% (346/389) were on antiviral therapy, 26.6% (105/395) had AIDS, 61.8% (244/395) were infected for more than one year, 70.9% (280/395) were ≥350 on CD4 cell count, 20.5% (81/395) missed drugs (Table 4). This evidence concerns the gene CD4 and AIDS.